APIXABAN ACCORD 2.5 mg FILM-COATED TABLETS

2. What you need to know before you take Apixaban Accord

Do not take Apixaban Accord

• If you are allergicto apixaban or any of the other ingredients of this medicine (listed in section 6)
• If you bleed excessively
• If you have a disease in an organof the body that increases the risk of severe bleeding (such as an active or recent stomach or intestinal ulcer, or recent brain hemorrhage)

• If you have a liver diseasethat increases the risk of bleeding (hepatic coagulopathy)
• If you are taking medicines to prevent blood clotting(e.g., warfarin, rivaroxaban, dabigatran, or heparin), except when switching treatment, while having an arterial or venous line and being treated with heparin to keep the line open, or when a tube is inserted into a blood vessel (catheter ablation) to treat an irregular heartbeat (arrhythmia).

Warnings and precautions

Tell your doctor, pharmacist, or nurse before taking this medicine if you have any of these conditions:

• An increased risk of bleeding, such as:
• • Bleeding disorders, including situations that result in a decrease in platelet activity
  • Uncontrolled high blood pressure
  • You are over 75 years old
  • You weigh 60 kg or less

• A severe kidney disease or if you are on dialysis
• A liver problem or history of liver problems

This medicine will be used with caution in patients with signs of altered liver function

• You had a catheter or received an injection in the spine(for anesthesia or pain relief), your doctor will tell you to wait at least 5 hours after removing the catheter before taking this medicine.
• You have a heart valve prosthesis
• If your doctor determines that your blood pressure is unstable or you are scheduled to receive another treatment or undergo surgery to remove the blood clot from your lungs

Be careful with Apixaban Accord

• If you know you have a disease called antiphospholipid syndrome (an immune system disorder that increases the risk of forming blood clots), inform your doctor to decide if it may be necessary to modify the treatment.

If you need to undergo surgery or a procedure that may cause bleeding, your doctor will tell you to temporarily stop taking this medicine for a while. If you are not sure if a procedure may cause bleeding, consult your doctor.

Children and adolescents

Apixaban Accord is not recommended for use in children and adolescents under 18 years of age.

Using Apixaban Accord with other medicines

Tell your doctor, pharmacist, or nurse if you are using, have recently used, or might use other medicines.

Some medicines may increase the effects of Apixaban Accord, and some medicines may decrease its effects. Your doctor will decide if you should be treated with Apixaban Accord if you are taking these medicines and if you should be kept under closer observation.

The following medicines may increase the effects of Apixaban Accord and increase the risk of unwanted bleeding:

• Some medicines for fungal infections(e.g., ketoconazole, etc.)
• Some antiviral medicines for HIV/AIDS(e.g., ritonavir)

• Other medicines to reduce blood clotting(e.g., enoxaparin, etc.)
• Pain relieversor anti-inflammatory medicines(e.g., acetylsalicylic acid or naproxen). Especially if you are over 75 years old and taking acetylsalicylic acid, there is a higher likelihood of bleeding.
• Medicines for high blood pressure or heart problems(e.g., diltiazem)
• Antidepressantscalled selective serotonin reuptake inhibitorsor serotonin-norepinephrine reuptake inhibitors

The following medicines may reduce the ability of Apixaban Accord to prevent blood clot formation.

• Medicines for the treatment of epilepsy or seizures(e.g., phenytoin, etc.)
• St. John's Wort(a herbal medicine for the treatment of depression)
• Medicines for the treatment of tuberculosisor other infections(e.g., rifampicin)

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

The effects of this medicine on pregnancy and the fetus are not known. You should not take this medicine if you are pregnant. Tell your doctor immediatelyif you become pregnant while taking this medicine.

It is not known if Apixaban Accord is excreted in human milk. Ask your doctor or pharmacist for advice before taking this medicine during breastfeeding. They will tell you whether to stop breastfeeding or whether to stop or not start taking Apixaban Accord.

Driving and using machines

Apixaban Accord has no influence on the ability to drive or use machines.

Apixaban Accord contains lactose (a type of sugar) and sodium.

If your doctor has told you that you have an intolerance to some sugars, talk to them before taking this medicine.

This medicine contains less than 1 mmol of sodium (23 mg) per tablet, which is essentially "sodium-free".

3. How to take Apixaban Accord

Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If you are not sure, ask your doctor, pharmacist, or nurse.

Dosage

Take the tablet with water. Apixaban Accord can be taken with or without food.

Try to take the tablets at the same time every day to achieve a better treatment effect.

If you have difficulty swallowing the tablet whole, talk to your doctor about other possible ways to take Apixaban Accord. The tablet can be crushed and mixed with water, 5% glucose in water, apple juice, or apple puree, immediately before taking it.

Instructions for crushing:

• Crush the tablets with a mortar or on a plate with the convex face of a spoon.

• Transfer all the powder carefully into a suitable container, mixing the powder with a small amount, for example, 30 ml (2 tablespoons), of water or any of the other liquids mentioned to make the mixture.
• Take the mixture.
• Rinse the mortar and pestle or the plate and spoon used to crush the tablet and the container with a small amount of water or one of the other liquids (e.g., 30 ml), and take that liquid.

If necessary, your doctor may also administer the crushed Apixaban Accord tablet mixed in 60 ml of water or 5% glucose in water through a nasogastric tube.

Take Apixaban Accord according to the following recommendations:

To prevent the formation of blood clots in hip or knee replacement surgery.

The recommended dose of Apixaban Accord is one 2.5 mg tablet twice a day.

For example, take one tablet in the morning and one in the evening.

You should take the first tablet between 12 and 24 hours after surgery.

If you have undergone major hipsurgery, you will generally take the tablets for a period of 32 to 38 days.

If you have undergone major kneesurgery, you will generally take the tablets for a period of 10 to 14 days.

To prevent the formation of a blood clot in the heart in patients with an irregular heartbeat and at least one additional risk factor.

The recommended dose of Apixaban Accord is one 5 mg tablet twice a day.

The recommended dose is one 2.5 mg tablet twice a day if:

• You have severely reduced kidney function
• Two or more of the following factors apply to you:
• • Your blood test results suggest poor kidney function (serum creatinine value of 1.5 mg/dl (133 micromoles/l) or higher)
  • You are 80 years old or older
  • Your weight is 60 kg or less

The recommended dose is one tablet twice a day, for example, take one tablet in the morning and one in the evening. Your doctor will tell you how long you should continue the treatment.

To treat blood clots in the veins of the legs and in the blood vessels of the lungs

The recommended dose is two 5 mg tabletstwice a day for the first 7 days, for example, two tablets in the morning and two tablets in the evening. After 7 days, the recommended dose is one 5 mg tablettwice a day, for example, one tablet in the morning and one in the evening.

To prevent blood clots from recurring after 6 months of treatment

The recommended dose is one 2.5 mg tablet twice a day, for example, one tablet in the morning and one in the evening.

Your doctor will tell you how long you should continue the treatment.

Your doctor may change your anticoagulant treatment as follows:

• Switching from Apixaban Accord to other anticoagulant medicines

Stop taking Apixaban Accord. Start treatment with other anticoagulant medicines (e.g., heparin) at the time you would take the next Apixaban Accord tablet.

• Switching from other anticoagulant medicines to Apixaban Accord

Stop taking other anticoagulant medicines. Start treatment with Apixaban Accord at the time you would take the next dose of the other anticoagulant medicine, and then continue as usual.

• Switching from treatment with anticoagulants that contain Vitamin K antagonists (e.g., warfarin) to Apixaban Accord

Stop taking the medicine that contains a Vitamin K antagonist. Your doctor will need to perform blood tests and tell you when to start taking Apixaban Accord.

• Switching from Apixaban Accord to treatment with anticoagulants that contain Vitamin K antagonists (e.g., warfarin)

If your doctor tells you to start taking a medicine that contains a Vitamin K antagonist, continue taking Apixaban Accord for at least 2 days after your first dose of the medicine that contains a Vitamin K antagonist. Your doctor will need to perform blood tests and tell you when to stop taking Apixaban Accord.

Patients undergoing cardioversion

If your heartbeat needs to be restored through a process called cardioversion, take this medicine at the times your doctor indicates to prevent blood clots in the blood vessels of the brain and other blood vessels in the body.

If you take more Apixaban Accord than you should

Tell your doctor immediatelyif you have taken a dose greater than the prescribed dose of Apixaban Accord. Take the medicine package to your doctor, even if there are no tablets left.

If you take more Apixaban Accord than the recommended dose, you may increase the risk of bleeding. If bleeding occurs, surgery, blood transfusions, or other treatments that can reverse the anti-factor Xa activity may be necessary.

If you forget to take Apixaban Accord

• Take the dose as soon as you remember and
• • Take the next dose of Apixaban Accord at the usual time
  • Then continue taking the medicine as usual

If you are not sure what to do or if you forget to take more than one dose,ask your doctor, pharmacist, or nurse.

If you stop taking Apixaban Accord

Do not stop taking this medicine without talking to your doctor first, because the risk of developing a blood clot may be greater if you stop the treatment too soon.

If you have any further questions on the use of this product, ask your doctor, pharmacist, or nurse.

4. Possible Adverse Effects

Like all medicines, Apixaban Accord can cause adverse effects, although not all people suffer from them. Apixaban Accord can be administered for three different diseases. The known adverse effects and the frequency at which they occur may be different and are therefore indicated separately below. For these conditions, the most frequent adverse effect of this medication is bleeding, which can put the patient's life at risk and requires immediate medical attention.

The following adverse effects have been reported when taking Apixaban Accord to prevent the formation of blood clots in hip or knee replacement surgeries.

Frequent Adverse Effects (may affect up to 1 in 10 people)

• Anemia, which can cause fatigue or paleness
• Bleeding, including:
• • Hematoma and swelling
• Nausea (feeling of discomfort)

Uncommon Adverse Effects (may affect up to 1 in 100 people)

• Decrease in the number of platelets in the blood (which can affect coagulation)
• Bleeding:
• • After surgery, including hematoma and swelling, bleeding or fluid discharge from the wound/surgical incision (suppuration), or at the injection site
  • From the stomach, intestine, or bright/red blood in the stool
  • Blood in the urine
  • From the nose
  • Vaginal
• Low blood pressure that can cause fainting or a faster heart rate
• Blood tests may show:
• • Abnormal liver function
  • Increased liver enzymes
  • Increased bilirubin, a byproduct of red blood cells, which can cause yellowing of the skin and eyes.
• Itching

Rare Adverse Effects (may affect up to 1 in 1,000 people)

• Allergic reactions (hypersensitivity) that can cause: swelling of the face, lips, mouth, tongue, and/or throat, and difficulty breathing. Inform your doctor immediatelyif you experience any of these symptoms.
• Bleeding:
• • In a muscle
  • In the eyes
  • From the gums and coughing up blood
  • From the rectum
• Hair loss

Frequency Not Known (cannot be estimated from available data)

• Bleeding:
• • In the brain or spinal cord
  • In the lungs or throat
  • In the mouth
  • In the abdomen or the space behind the abdominal cavity
  • Hemorrhoidal
  • Tests showing blood in the stool or urine
• Skin rash that can form blisters and resemble small targets (dark spots in the center surrounded by a paler area, with a dark ring around) (erythema multiforme).
• Inflammation of the blood vessels (vasculitis) that can cause skin rash, appearance of round, smooth red spots under the skin surface, or hematomas.

The following adverse effects have been reported when taking Apixaban Accord to prevent the formation of blood clots in the heart in patients with irregular heart rhythm and at least one additional risk factor.

Frequent Adverse Effects (may affect up to 1 in 10 people)

• Bleeding, including:
• • In the eyes
  • In the stomach or intestine
  • From the rectum
  • Blood in the urine
  • From the nose
  • From the gums
  • Hematoma and swelling
• Anemia, which can cause fatigue or paleness
• Low blood pressure that can cause fainting or a faster heart rate
• Nausea (general discomfort)
• Blood tests may show:
• • An increase in gamma-glutamyl transferase (GGT)

Uncommon Adverse Effects (may affect up to 1 in 100 people)

• Bleeding:
• • In the brain or spinal cord
  • In the mouth or coughing up blood
  • In the abdomen or vagina
  • Bright/red blood in the stool
  • Bleeding after surgery, including hematoma and swelling, bleeding or fluid discharge from the wound/surgical incision (suppuration), or at the injection site
  • Hemorrhoidal
  • Tests showing blood in the stool or urine
• Decrease in the number of platelets in the blood (which can affect coagulation)
• Blood tests may show:
• • Abnormal liver function
  • Increased liver enzymes
  • Increased bilirubin, a byproduct of red blood cells, which can cause yellowing of the skin and eyes.
• Skin rash
• Itching
• Hair loss
• Allergic reactions (hypersensitivity) that can cause: swelling of the face, lips, mouth, tongue, and/or throat, and difficulty breathing. Inform your doctor immediatelyif you experience any of these symptoms.

Rare Adverse Effects (may affect up to 1 in 1,000 people)

• Bleeding:
• • In the lungs or throat
  • Within the muscle

Very Rare Adverse Effects (may affect up to 1 in 10,000 people)

• Skin rash that can form blisters and resemble small targets (dark spots in the center surrounded by a paler area, with a dark ring around) (erythema multiforme).

Frequency Not Known (cannot be estimated from available data)

• Inflammation of the blood vessels (vasculitis) that can cause skin rash, appearance of round, smooth red spots under the skin surface, or hematomas.

The following adverse effects have been reported when taking Apixaban Accord to treat or prevent blood clots from recurring in the veins of the legs and in the blood vessels of the lungs.

Frequent Adverse Effects (may affect up to 1 in 10 people)

• Bleeding, including:
• • From the nose
  • From the gums
  • Blood in the urine
  • Hematoma and swelling
  • From the stomach, intestine, or rectum
  • In the mouth
  • Vaginal
• Anemia, which can cause fatigue or paleness
• Decrease in the number of platelets in the blood (which can affect coagulation)
• Nausea (feeling of discomfort)
• Skin rash
• Blood tests may show:
• • An increase in gamma-glutamyl transferase (GGT) or alanine aminotransferase (GPT)

Uncommon Adverse Effects (may affect up to 1 in 100 people)

• Low blood pressure that can cause fainting or a faster heart rate
• Bleeding:
• • In the eyes
  • In the mouth or coughing up blood
  • Bright/red blood in the stool
  • Tests showing blood in the stool or urine
  • Bleeding after surgery, with hematoma and swelling, bleeding or fluid discharge from the wound/surgical incision (suppuration), or at the injection site
  • Hemorrhoidal
  • Within a muscle
• Itching
• Hair loss
• Allergic reactions (hypersensitivity) that can cause: swelling of the face, lips, mouth, tongue, and/or throat, and difficulty breathing. Contact your doctor immediatelyif you experience any of these symptoms.
• Blood tests may show:
• • Abnormal liver function
  • Increased liver enzymes
  • Increased bilirubin, a byproduct of red blood cells, which can cause yellowing of the skin and eyes.

Rare Adverse Effects (may affect up to 1 in 1,000 people)

Bleeding:

• In the brain or spinal cord
• In the lungs

Frequency Not Known (cannot be estimated from available data)

• Bleeding:
• In the abdomen or the space behind the abdominal cavity

• Skin rash that can form blisters and resemble small targets (dark spots in the center surrounded by a paler area, with a dark ring around) (erythema multiforme).

• Inflammation of the blood vessels (vasculitis) that can cause skin rash, appearance of round, smooth red spots under the skin surface, or hematomas.

Reporting of Adverse Effects

If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that is not listed in this leaflet. You can also report them directly through the national reporting system included in Appendix V. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.

5. Storage of Apixaban Accord

Keep this medication out of sight and reach of children.

Do not use this medication after the expiration date shown on the packaging and on each blister, after "EXP". The expiration date is the last day of the month indicated.

This medication does not require special storage conditions.

Medicines should not be disposed of through wastewater or household waste. Ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.

6. Package Contents and Additional Information

Composition of Apixaban Accord

• The active ingredient is apixaban. Each tablet contains 2.5 mg of apixaban.
• Other ingredients are:
• • Core of the tablet: , microcrystalline cellulose, sodium croscarmellose, sodium lauryl sulfate, magnesium stearate.
  • Coating: , hypromellose, titanium dioxide (E171), triacetin, yellow iron oxide (E172)

Appearance of the Product and Package Contents

The film-coated tablets are round, biconvex, yellow in color, and have "IU1" engraved on one side, and are smooth on the other.

They are available in aluminum-PVC/PVdC blisters of 10, 14, 20, 28, 56, 60, 100, 112, 168, and 200 film-coated tablets.

They are available in single-dose aluminum-PVC/PVdC blisters of 10 x 1, 20 x 1, 28 x 1, 56 x 1, 60 x 1, 100 x 1, and 168 x 1 film-coated tablets.

HDPE bottle with a child-resistant polypropylene cap with 60, 100, 168, 180, 200, and 1,000 film-coated tablets.

Not all pack sizes may be marketed.

Patient Information Card: Handling of Information

Inside the Apixaban Accord packaging, along with the leaflet, you will find a Patient Information Card or your doctor may give you a similar card.

This Patient Information Card includes useful information for you and will alert other doctors that you are being treated with Apixaban Accord. You must keep this card with you at all times.

1. Take the card

1. Separate the language you need (this is facilitated through the perforated ends)

1. Complete the following sections or ask your doctor to complete them:

• Name:
• Date of birth:
• Indication:
• Dose: ........mg twice a day
• Doctor's name:
• Doctor's phone number:

1. Fold the card and carry it with you at all times

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder

Accord Healthcare S.L.U.

World Trade Center, Moll de Barcelona, s/n,

Edifici Est, 6a Planta,

08039 Barcelona,

Spain

Manufacturer

LABORATORI FUNDACIÓ DAU

C/ C, 12-14 Pol. Ind. Zona Franca, Barcelona,

08040 Barcelona, Spain

Accord Healthcare Polska Sp. z.o.o.

ul.Lutomierska 50,

95-200, Pabianice,

Poland

Pharmadox Healthcare Limited

KW20A Kordin Industrial Park,

Paola PLA 3000, Malta

Date of the Last Revision of this Leaflet:{MM/YYYY}.

Detailed information on this medication is available on the European Medicines Agency website http://www.ema.europa.eu/.